The ICR has been instrumental in the development of several groundbreaking cancer treatments. Notably, it has played a key role in the discovery and development of targeted therapies such as hormone therapies for breast cancer and drugs like abiraterone for prostate cancer. The institute's research has also contributed to advances in radiotherapy and the identification of new biomarkers for cancer diagnosis and prognosis.